---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-021464"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:48:24.094075+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Sanuwave records Q4 revenue $13.4M (+29.7% YoY); FY rev $44.1M; guides FY26 $51-55M

## Summary
- Q4 2025 revenue record $13.4M (+29.7% YoY); FY 2025 revenue record $44.1M (+35% YoY).
- GAAP operating income $2.0M Q4 ($4.9M FY); net income $7.7M Q4 vs loss $13.3M Q4 2024.
- Adjusted EBITDA Q4 $4.8M vs $3.7M YoY; FY $13.6M vs $7.2M YoY.
- Guides Q1 2026 rev $9.6-10.3M (+3-10%); FY 2026 rev $51-55M (+16-25% vs FY25).
- Sold 255 UltraMist systems in Q4 (up from 135); consumables rev +10.6% to $6.5M.

## SEC filing metadata
- accession: 0001628280-26-021464
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828026021464/0001628280-26-021464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828026021464/snwv-20260326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-021464
- JSON: https://secwatch.observer/filing/0001628280-26-021464.json
- Plain text: https://secwatch.observer/filing/0001628280-26-021464.txt

## Key facts
- Earnings Releases
  SANUWAVE Health, Inc. reported the fourth quarter and fiscal year ended December 31, 2025 results: revenue $13.4 million, net income $7.7 million. Guidance initiated.
  - Period: the fourth quarter and fiscal year ended December 31, 2025
  - Revenue: $13.4 million
  - Net income: $7.7 million
  - Guidance: initiated
  - Result: reported results
  source text: forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 Q4 2025 revenues were $13.4 million, up 29.7% from Q4 2024. This was an all-time quarterly record for the Company. Full year 2025 revenues were $44.1 million up 35.0% from full year 2024 revenues. This was an
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000162828026021464/0001628280-26-021464-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.